Lefamulin最初由Nabriva开发,2018年3月仑胜医药获得在大中华区,包括中国大陆、香港、澳门、台湾开...查看全文
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ CORRESP [Cover] - Correspondence Filed: 2017-08-08 AccNo: 0001104659-17-050146 Size: 10 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-08-31,10% Owner,HBM Healthcare Investments (Ca ,卖出,639普通股, $9.50
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-08-31 AccNo: 0001104659-17-054979 Size: 152 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certai...
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-08-21 AccNo: 0001104659-17-052922 Size: 19 KBItem 8.01: Other Events 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ DEF 14A - Other definitive proxy statements Filed: 2017-08-18 AccNo: 0001047469-17-005313 Size: 826 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-08-11 AccNo: 0001104659-17-051364 Size: 20 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain...
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ EFFECT - Notice of Effectiveness Filed: 2017-08-10 AccNo: 9999999995-17-002091 Size: 1 KB 网页链接
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-08-08,10% Owner,HBM Healthcare Investments (Ca ,卖出,2013普通股, $10.50
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 内部交易: 2017-08-07,10% Owner,HBM Healthcare Investments (Ca ,卖出,17790普通股, $10.50
$Nabriva Therapeutics plc - Ordinary Shares(NBRV)$ 8-K - Current report Filed: 2017-08-07 AccNo: 0001104659-17-049798 Size: 241 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接